Stoke Therapeutics, Inc. (STOK) vs Zenas BioPharma, Inc. (ZBIO)
- Stoke Therapeutics, Inc. STOK 24.17 −1.79%
- Zenas BioPharma, Inc. ZBIO 24.67 −2.87%
Stoke Therapeutics, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Stoke Therapeutics, Inc. and Zenas BioPharma, Inc. are of similar size ($1.7B and $1.6B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −753.6%) and the higher return on invested capital (0.00% vs −264.8%). Across the 13 metrics below, Stoke Therapeutics, Inc. leads on 7 and Zenas BioPharma, Inc. on 6.
Valuation
Profitability
| Metric | STOK | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (809.69%) | 0.00% | 0.00% |
| Net margin | (753.60%) | 0.00% | 0.00% |
| Free cash flow margin | (654.92%) | 0.00% | 0.00% |
| Return on equity | (61.10%) | (199.04%) | (56.36%) |
| Return on assets | (53.41%) | (97.39%) | (48.04%) |
| Return on invested capital | (264.77%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack